Xencor, Inc.
Status: Publicly traded
Direct answer
Xencor, Inc. is publicly traded on NASDAQ under the ticker XNCR.
Xencor Inc., a biopharmaceutical firm headquartered in Monrovia, California, and established in 1997, operates as a clinical-stage entity. Its central mission involves the discovery and sophisticated engineering of monoclonal antibody and cytokine therapeutics, primarily aimed at treating patients afflicted with cancer and autoimmune disorders. The company is associated with several notable therapies currently in...
Can you invest in Xencor, Inc.?
Yes. Xencor, Inc. trades publicly on NASDAQ as XNCR.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Xencor, Inc.
Detailed equity research is provided by MarketSnap.